Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

0QSS

Phaxiam Therapeutics (0QSS)

Phaxiam Therapeutics
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0QSS
FechaHoraFuenteTítuloSímboloCompañía
20/03/202412:00UK RegulatoryPHAXIAM Therapeutics publie ses résultats annuels 2023 et fait le point sur ses activitésLSE:0QSSPhaxiam Therapeutics
20/03/202412:00UK RegulatoryPHAXIAM Announces 2023 Full-Year Results and Provides Business UpdateLSE:0QSSPhaxiam Therapeutics
11/03/202401:00UK RegulatoryPHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketLSE:0QSSPhaxiam Therapeutics
11/03/202401:00UK RegulatoryPHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketLSE:0QSSPhaxiam Therapeutics
05/03/202411:00UK RegulatoryMonthly information related to total number of voting rights and shares composing the share capital - February 29, 2024LSE:0QSSPhaxiam Therapeutics
05/03/202411:00UK RegulatoryInformation mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024LSE:0QSSPhaxiam Therapeutics
20/02/202415:05UK RegulatoryPHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketLSE:0QSSPhaxiam Therapeutics
20/02/202415:05UK RegulatoryPHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketLSE:0QSSPhaxiam Therapeutics
06/02/202415:05UK RegulatoryInformation mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024LSE:0QSSPhaxiam Therapeutics
06/02/202415:05UK RegulatoryMonthly information related to total number of voting rights and shares composing the share capital - January 31, 2024LSE:0QSSPhaxiam Therapeutics
 Showing the most relevant articles for your search:LSE:0QSS